Multiple Sclerosis Flashcards

1
Q

MS definitions and presentations

A
  • autoimmune de-myelination liaisons of CNS white matter (not PNS matter)
  • lesions (plaques) are multi focal (2 or more)
  • localization: any level of the CNS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Complaints of MS

A

Wide range of deficits on initial or recurring attacks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Temporal profile of MS

A
  • onset can be acute, but typically subacute or insidious

- course: typically episodic or cyclic, relapse-remitting, can become chronic and progressive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnosis of MS

A

Starts with history and neuro exam evidence for 2+ lesions in CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

OD significance of MS

A
  • MS is often preceded by transient episode of optic neuritis (visual loss)
  • MS often involves visual, pupillary, or oculomotor deficits
  • importance of recognizing that seemingly in-related deficits could be MS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathogensis of MS

A

-small breaches of BBB (possibly triggered by microglia) or blood CSF barrier (in choroid plexus) allow lymphocytes into CNS, followed by an AI attack involving damage to oligodendrocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Original hypothesis on specific mechanism of MS

A
  • Ab against Myelin Basic Protein

- T cells release cytokines toxic to oligodendrocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Secondary tissue changes in MS

A
  • following oligodendrocyte damage/death, macrophages attack debris and myelin sheath.
  • astrocytes form glial scar around zone of damage
  • axons can survive in non-myleinated state, or there can be axonal damage as well
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Distribution of MS

A

Multi-focal

-evidence for 2 or more focal lesions in the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Temporal profile of MS

A
  1. 2 or more attacks separated by > 1m apart or

2. Chonric and progressive lasting at least 6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Complaints in MS

A
  • visual, cognitive, psychiatric, motor, sensory, pain
  • visual system: visual loss localizing from optic disc to visual cortex
  • mental status: cognitive impairments, psychiatric symptoms
  • cranial nerves: motor, sensory deficits, vertigo, pupillary dysregulation
  • motor systems: weakness, fatigue, impaired coordination/balance
  • sensory systems: generally sensory loss, also parenthesia/pain
  • autonomic dysfunction: bladder, bowel, sexual
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Common presentations of MS with optometric significance

A
  • history of optic neuritis episode
  • pupillary constriction of dilation deficits, horners syndrome
  • EOMS: nerve palsies, conjugate gaze palsy, internuclear ophthalmoplegia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Common precursor to MS

A

Optic neuritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

____ of patients with optic neuritis later develop MS

A

50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Inflammatory de-myelination of the optic nerves

A

Optic neuritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Etiology of optic neuritis

A
  1. Inflammatory process triggered during or after resolution of viral infection
  2. Pro inflammatory chemical exposure
  3. Vitamin B12 deficiency
17
Q

Onset of optic neuritis

A

Typically 30-45 years, but can be later

18
Q

Gender and optic neuritis

A

2x more likely in females

19
Q

Visual loss due to optic neuritis

A

Usually monocular vision loss, central scotoma, reduced acuity around scotoma, impaired color detection, can be complete monocular vision loss

20
Q

OD exam for optic neuritis

A

Depends on whether inflammation extends to optic disc or is limited to retro-bulbar segment of optic nerve. Thus, optic disc can be swollen and inflamed or normal. Prior episodes can lead to optic disc pallor

21
Q

Exacerbating or precipitating factors for optic neuritis

A
Infection
Heat or over heating (VF deficits especially sensitive) 
Dehydration 
Sleep deprivation
Anemia 
Dietary factors
22
Q

Heat induced transient vision loss

A

Uthoff phenomenon

Transiently induced by hot bath

23
Q

Temporal profile of optic neuritis

A
  1. Cyclic/episodic, relapse-remitting

2. Chronic and progressive, aka “primary progressive MS”

24
Q

Less severe outcomes of MS

A

If 1st attack had an acute onset, few types of symptoms/signs, predicts rapid/complete remission. More likely to follow relapse-remitting course. Caveat to “less severe” prediction: relapse-remitting patient’s can potentially develop secondary progression MS where plaques become permanent lesion sites

25
Q

More severe outcomes of MS

A

If 1st attack was more gradual (subacute or insidious), multiple functional systems affected, spinal cord involvement, more at risk for primary progressive MS

26
Q

Epidemiology of MS

A
  • 1:1000
  • 2x more in females
  • 20-40y
  • more common in caucasians, especially in higher latitude regions
  • genetic risk: siblings 2.6% risk, more in twins
  • mutations in IL-2 and IL-7 possibly
27
Q

Diagnostic criteria for MS

A
  • MRI evidence or 2 or more plaques in white matter
  • Evoked potential findings: reduced conduction velocity
  • CSF analysis by electrophoresis: “oligoclonal bands”
28
Q

MRI of 2 or more white matter plaques in MS

A
  • plaques can be supratentorial, infratentorial, or in spinal cord
  • often appear as fingers extending from periventricular zones
  • MRI with contrast (gadolinium) can highlight plaques
  • plaques can heal or can stabilize and become permanents lesions
29
Q

Evoked potentials for MS

A

Reduced conduction velocity (increased latency)

-visual, auditory, or somatosensory evoked potentials

30
Q

CSF analysis by electrophoresis in MS

A

Oligoclonal bands

  • increased protein, increased IgG, normal or increased lymphocytes
  • elevated lymphocytes: up to 50 cells per ul
  • oligoclonal bands refers abnormal bands at specific molecular weights
  • bands-large amounts of same immunoglobulin (IgG) being produced
  • 85% sensitivity for MS
  • 92% specificity for MS
31
Q

Short term treatment for MS

A

For acute attack (Rapid onset)

  • glucocorticoids: methylprednisone or prednisone
  • rapid and potent immunosuppressive strategy
32
Q

Long term treatment for MS: 1st line

A

Interferon 1-beta

  • increases suppressor T cells systemically
  • decreases lymphocytes invasion of CNS across barriers
  • decreases inflammatory cytokines from T cells
  • decreases antigen presentation mechanisms
33
Q

Long term treatment for MS: 2nd line

A

Being developed

  • off-label use of chemotherapies to reduce lymphocyte proliferation
  • targeting enzymes in lymphocytes to reduce proliferation, invasion, inflamamtion
  • monoclonal Ab to neutralize lymphocyte-mediated inflammation
  • Ab of mature oligodendrocyte from glial stem cells, increasing oligodendrocytes
34
Q

Differential Dx in MS

A

Overlap among MS and other neuoimmunological and demyelinating diseases

  • neuromyelitis optica
  • acute disseminated encephalmyelitis (ADEM)
  • progressive multifocal leukoencephaolopathy
35
Q

Neuromyelitis optica as a DiffDx for MS

A

AI disease involving Ab against aquaporin-4. Lesion localization is specifically combination of optic nerve and spinal cords. Multi focal and stable

36
Q

Acute dissemination encephalomyelitis (ADEM) as DiffDx for MS

A

AI mechanism triggered by recent infection or VAx, attacks against gray matter as well as whit matter, rapid onset of neuro signs, initally focal or multifocal signs then diffuse localization/ distribution. Can be stable or remission

37
Q

Progressive multifocal leukoencephalopathy as diffdx for MS

A

Viral infection of the CNS that evidently most affects oligodendrocytes. Chronic progressive course of white matter damage/lesions